Nissay Asset Management Corp Japan Increases Stake in Danaher Corporation $DHR

Nissay Asset Management Corp Japan raised its position in shares of Danaher Corporation (NYSE:DHR) by 4.4% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 84,803 shares of the conglomerate’s stock after purchasing an additional 3,596 shares during the quarter. Nissay Asset Management Corp Japan’s holdings in Danaher were worth $16,153,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. EP Wealth Advisors LLC purchased a new stake in Danaher in the 2nd quarter worth $3,807,000. Northwestern Mutual Wealth Management Co. lifted its position in shares of Danaher by 303.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after acquiring an additional 186,584 shares in the last quarter. Puzo Michael J bought a new position in shares of Danaher in the second quarter worth about $8,624,000. Madison Asset Management LLC bought a new position in shares of Danaher in the second quarter worth about $85,451,000. Finally, Legal & General Group Plc grew its position in shares of Danaher by 1.0% during the fourth quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock worth $1,029,061,000 after purchasing an additional 43,169 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

DHR has been the topic of a number of research analyst reports. Wells Fargo & Company lowered their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 22nd. Weiss Ratings raised shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 15th. Stifel Nicolaus reduced their price objective on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Royal Bank Of Canada boosted their target price on shares of Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a report on Wednesday, July 22nd. Finally, Piper Sandler began coverage on shares of Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $228.91.

Danaher Price Performance

NYSE:DHR opened at $216.41 on Friday. The business’s 50-day moving average is $199.46 and its 200 day moving average is $192.52. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a market capitalization of $152.13 billion, a P/E ratio of 38.44, a P/E/G ratio of 2.69 and a beta of 0.78. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same quarter last year, the business posted $0.77 EPS. The firm’s revenue for the quarter was up 5.5% compared to the same quarter last year. On average, equities research analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.